Oxamate Attenuates Glycolysis and ER Stress in Silicotic Mice

Int J Mol Sci. 2022 Mar 10;23(6):3013. doi: 10.3390/ijms23063013.

Abstract

Glycolysis and ER stress have been considered important drivers of pulmonary fibrosis. However, it is not clear whether glycolysis and ER stress are interconnected and if those interconnections regulate the development of pulmonary fibrosis. Our previous studies found that the expression of LDHA, a key enzyme involved in glycolysis, was increased in silica-induced macrophages and silicotic models, and it was closely related to silicosis fibrosis by participating in inflammatory response. However, whether pharmacological inhibition of LDHA is beneficial to the amelioration of silicosis fibrosis remains unclear. In this study, we investigated the effects of oxamate, a potent inhibitor of LDHA, on the regulation of glycolysis and ER stress in alveolar macrophages and silicotic mice. We found that silica induced the upregulation of glycolysis and the expression of key enzymes directly involved in ER stress in NR8383 macrophages. However, treatment of the macrophages and silicotic mice with oxamate attenuated glycolysis and ER stress by inhibiting LDHA, causing a decrease in the production of lactate. Therefore, oxamate demonstrated an anti-fibrotic role by reducing glycolysis and ER stress in silicotic mice.

Keywords: ER stress; glycolysis; macrophages; oxamate; silicosis.

MeSH terms

  • Animals
  • Glycolysis
  • Mice
  • Mice, Inbred C57BL
  • Pulmonary Fibrosis* / metabolism
  • Silicon Dioxide / adverse effects
  • Silicosis* / metabolism

Substances

  • Silicon Dioxide